Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
Condition(s):Mantle Cell LymphomaLast Updated:December 19, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Mantle Cell LymphomaLast Updated:December 19, 2023Recruiting
Condition(s):Lymphoma, Mantle-CellLast Updated:January 25, 2024Recruiting
Condition(s):Lymphoma, Mantle-CellLast Updated:October 21, 2022Recruiting
Condition(s):Follicular Lymphoma; Diffuse Large B Cell Lymphoma; Mantle Cell LymphomaLast Updated:January 31, 2023Recruiting
Condition(s):Chronic Lymphocytic Leukemia; Mantle Cell LymphomaLast Updated:December 21, 2023Recruiting
Condition(s):Mantle Cell Lymphoma; Refractory LymphomaLast Updated:February 15, 2024Recruiting
Condition(s):Mantle Cell Lymphoma; MCLLast Updated:January 22, 2024Recruiting
Condition(s):Mantle Cell LymphomaLast Updated:March 22, 2024Not yet recruiting
Condition(s):Mantle Cell Lymphoma (MCL)Last Updated:June 6, 2022Recruiting
Condition(s):Mantle Cell LymphomaLast Updated:October 30, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.